Rucaparib Camsylate | Interleukin Related interleukin-related.com

Product Name :
Rucaparib Camsylate

Search keywords :
Rucaparib

drugId :
null

Target Vo:
Poly (ADP-Ribose) Polymerase 2

Target Vo Short Name :
PARP-2

Moa_Name:
Poly (ADP-Ribose) Polymerase 3 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2016

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Clovis Oncology Inc

Active Indication_Name:
Prostatic Neoplasms

In Active Indication_Name:
Urinary Bladder Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKC alpha Rabbit mAb MedChemExpress
FKBP51 Rabbit mAb Autophagy
DDIT3 Antibody: DDIT3 Antibody is an unconjugated, approximately 19 kDa, rabbit-derived, anti-DDIT3 polyclonal antibody. DDIT3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Interleukin Related

Related Posts